DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Dependence
Adult Attention Deficit Hyperactivity Disorder

Interventions: Drug: Adderall-XR
Drug: Placebo

First Posted Date: 2007-11-04

Last Posted Date: 2019-04-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 139

Registration Number: NCT00553319

Locations: 🇺🇸
STARS, New York, New York, United States
🇺🇸
Ambulatory Research Center/Fairview University Psychiatry Dept, Minneapolis, Minnesota, United States

A Pilot Study Assessing EmSam in Bipolar Depression

Phase 4

Terminated

Conditions: Bipolar Depression

Interventions: Drug: EmSam

First Posted Date: 2007-09-26

Last Posted Date: 2014-10-28

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 3

Registration Number: NCT00535262

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder

Phase 4

Completed

Conditions: Borderline Personality Disorder

Interventions: Behavioral: Supportive psychotherapy
Drug: Fluoxetine
Behavioral: Dialectical Behavior Therapy

First Posted Date: 2007-09-21

Last Posted Date: 2024-01-05

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 91

Registration Number: NCT00533117

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)

Phase 2

Completed

Conditions: Depersonalization Disorder

Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS)

First Posted Date: 2007-09-14

Last Posted Date: 2014-09-22

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 10

Registration Number: NCT00529217

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression

Phase 2

Completed

Conditions: Panic Disorder
Major Depressive Disorder

Interventions: Device: Sham Repetitive Transcranial Magnetic Stimulation (rTMS)
Device: Active Repetitive Transcranial Magnetic Stimulation (rTMS)

First Posted Date: 2007-08-27

Last Posted Date: 2014-09-22

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 25

Registration Number: NCT00521352

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Does Dual Therapy Hasten Antidepressant Response?

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: escitalopram + bupropion
Drug: bupropion extra long (XL)
Drug: escitalopram

First Posted Date: 2007-08-22

Last Posted Date: 2017-10-04

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 245

Registration Number: NCT00519428

Locations: 🇨🇦
University of Ottawa, Institute of Mental Health Research, Ottawa, Ontario, Canada
🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)

Phase 2

Terminated

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Device: Transcranial Magnetic Stimulation (TMS)
Device: repetitive transcranial magnetic stimulation

First Posted Date: 2007-08-16

Last Posted Date: 2017-01-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 14

Registration Number: NCT00517075

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression

Phase 4

Completed

Conditions: Depression

Interventions: Device: Electroconvulsive Therapy (ECT)

First Posted Date: 2007-06-18

Last Posted Date: 2014-08-18

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 180

Registration Number: NCT00487500

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Treating Depression With Transcranial Direct Current Stimulation (tDCS)

Phase 1

Completed

Conditions: Depression

Interventions: Device: transcranial direct current stimulation
Device: iomed phoresor transcranial direct current stimulation

First Posted Date: 2007-06-04

Last Posted Date: 2013-05-20

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 20

Registration Number: NCT00481988

Locations: 🇺🇸
New York State Psychiatric Institute, New York City, New York, United States

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence

Phase 2

Completed

Conditions: Heroin Dependence
Opioid Dependence

Interventions: Drug: Vivitrol
Drug: memantine

First Posted Date: 2007-05-21

Last Posted Date: 2018-07-17

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 82

Registration Number: NCT00476242

Locations: 🇺🇸
STARS, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy